Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

Researcher Publications

Steven K. Libutti, MD, FACS

Selected Publications

  1. Serrano OK, Love C, Goldman I, Huang K, Ng N, Abraham T, Da Silva R, Friedmann P, Libutti SK, Kennedy TJ. The value of FDG-PET in the staging of gastricadenocarcinoma: A single institution retrospective review. J Surg Oncol. 2016 May;113(6):640-6. doi: 10.1002/jso.24190. PubMed PMID: 27115836.
  2. Kwon M, Kim JH, Rybak Y, Luna A, Hun Choi C, Chung JY, Hewitt SM, Adem A,Tubridy E, Lin J, Libutti SK. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer. Oncotarget. 2016 Oct 20. doi: 10.18632/oncotarget.12784. [Epub ahead of print] PubMed PMID: 27776341.
  3. Libutti SK. Editorial: Treatment decision making in the era of genetic testing and molecular diagnostics. Surgery. 2017 Jan;161(1):228-229. doi: 10.1016/j.surg.2016. 10.009. PubMed PMID: 27863788.
  4. Libutti SK. Of mice and men(in) and what I have learned from both. Surgery. 2017 Jan;161(1):1-11. doi: 10.1016/j.surg.2016.10.004. PubMed PMID: 27865595.
  5. Chandra D, Selvanesan BC, Yuan Z, Libutti SK, Koba W, Beck A, Zhu K, Casadevall A, Dadachova E, Gravekamp C. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect. Oncotarget. 2017 Feb 6. doi: 10.18632/oncotarget.15117. [Epub ahead of print]. PubMed PMID: 28186976.
  6. Frank SJ, Goldman-Yassen AE, Koenigsberg T, LibuttiSK, Koenigsberg M. Sensitivity of 3-Dimensional Sonography in Preoperative Evaluation of Parathyroid Glands in Patients With Primary Hyperparathyroidism. J Ultrasound Med. 2017 May 24. doi: 10.1002/jum.14245. [Epub ahead of print] PubMed PMID: 28543268.
  7. Singh S, Carnaghi C, Buzzoni R, Pommier RF, Raderer M, Tomasek J, Lahner H, Valle JW, Voi M, Bubuteishvili-Pacaud L, Lincy J, Wolin E, Okita N, LibuttiSK, Oh DY, Kulke M, Strosberg J, Yao JC, Pavel ME, Fazio N. RAD001 in Advanced Neuroendocrine Tumors, Fourth Trial (RADIANT-4) Study Group. Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary. Neuroendocrinology. 2017 May 24. doi: 10.1159/000477585. [Epub ahead of print.] PubMed PMID: 28554173.
  8. Wang H, Bender A, Wang P, Karakose E, Inabnet WB, Libutti SK, Arnold A, Lambertini L, Stang M, Chen H, Kasai Y, Mahajan M, Kinoshita Y, Fernandez-Ranvier G, Becker TC, Takane KK, Walker LA, Saul S, Chen R, Scott DK, Ferrer J, Antipin Y, Donovan M, Uzilov AV, Reva B, Schadt EE, Losic B, Argmann C, Stewart AF. Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas. Nat Commun. 2017 Oct 3;8(1):767. doi: 10.1038/s41467-017-00992-9. PubMed PMID: 28974674.
  9. Tirosh A, Sadowski SM, Linehan WM, LibuttiSK, Patel D, Nilubol N, Kebebew E. Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease. JAMA Oncol. 2018 Jan 1;4(1):124-126. doi: 10.1001/jamaoncol.2017.3428. PubMed PMID: 29075773
  10. Snyder SK, Angelos P, Carty SE, Doherty GM, Howe JR, Lee JA, Libutti SK, Miller BS, Parangi S, Patel KN, Sippel RC, Sturgeon C, Wang TS, Yip L, Zeiger MA. Injection of bulking agents for laryngoplasty. Surgery. 2018 Jan;163(1):6-8. doi: 10.1016/ j.surg.2017.08.019. Epub 2017 Nov 9. PubMed PMID: 29129367
  11. Salazar R, Garcia-Carbonero R, Libutti SK, Hendifar AE, Custodio A, Guimbaud R, Lombard-Bohas C, Ricci S, Klümpen HJ, Capdevila J, Reed N, Walenkamp A, Grande E, Safina S, Meyer T, Kong O, Salomon H, Tavorath R, Yao JC. Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors. Oncologist. 2017 Dec 14. pii: theoncologist.2017-0144. doi: 10.1634/theoncologist.2017-0144. [Epub ahead of print] PubMed PMID: 29242283.
  12. Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C. Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model. Front Genet. 2018 Jan 23;9:6. doi: 10.3389/fgene.2018.00006. eCollection 2018. PubMed PMID: 29410677.
  13. Nilubol N, Yuan Z, Paciotti GF, Tamarkin L, Sanchez C, Gaskins K, Freedman EM, Cao S, Zhao J, Kingston DGI, Libutti SK, Kebebew E. Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors. J Natl Cancer Inst. 2018 Feb 22. doi: 10.1093/jnci/djy003. [Epub ahead of print] PubMed PMID: 29481652.
  14. Faustino LC, Lombardi A, Madrigal-Matute J, Owen RP, Libutti SK, Tomer Y. Interferon Alpha Triggers Autoimmune Thyroid Diseases via Lysosomal-Dependent Degradation of Thyroglobulin. J Clin Endocrinol Metab. 2018 Aug 2. doi: 10.1210/jc.2018-00541. [Epub ahead of print] PMID: 30113675.
  15. Yuan Z, Gardiner JC, Maggi EC, Adem A, Zhang G, Lee S, Romanienko P, Du YN, LibuttiSK. Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation. Cancer Gene Ther. 2018 Sep 7. doi: 10.1038/s41417-018-0046-x. [Epub ahead of print] PMID: 30190513.

Return to member profile